CORCEPT THERAPEUTICS INC — Director's Dealing 2016

Jul 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-07-21

Reporting Person: MAHONEY DAVID L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-21	Stock Option (Right to Buy)	$5.86	A	30000	Acquired	2026-07-21	Common Stock (30000)	Direct

Footnotes

F1: Exercisable ratably on each monthly anniversary of June 27, 2016 over one-year period.